| abstract |
The invention is a method of treating endotoxic shock in a mammal which compnses administering to the mammal a therapeutically effective amount of an antagonist to Platelet Activating Factor in combination with a therapeutically effective amount of one or more monoclonal or polyclonal antibodies directed towards either Tumor Necrosis Factor a, Interieukin-1β, Gamma Interferon, or bacterial cell wall lipopolysaccharides. |